Valeris, a fully integrated life sciences commercialization partner to the healthcare value chain, is naming Scott Filosi Chief Commercial Officer.

The company provides commercialization solutions to more than 500 life sciences customers. Moreover, it works on behalf of those companies to improve patient access and adherence to critical new medications.

In his role, Filosi will lead Valeris’ commercial organization, helping accelerate the company’s growth and strengthening execution and partner relationships.

New Chief Commercial Officer Experience

Filosi’s resume touches upon multiple areas of expertise: commercial strategy, distribution, market access, patient services, pricing, and trade. He comes to Valeris from Verona Pharma, where he was Head of U.S. and Global Market Access, Pricing & Trade.

Previously, he served as CEO at both Luzsana Bio and Mirror Bio.

Additionally, earlier in Filosi’s career, he held leadership positions at Merck KGaA, UCB Pharma, Boehringer Ingelheim, and Johnson & Johnson.

Valeris CEO Discusses Company Direction

“We are incredibly excited to welcome Scott to our team,” said Valeris CEO Robert Truckenmiller. “Valeris [brings] together market access, payer intelligence, and patient support to deliver confident commercialization in a rapidly evolving landscape.”

Truckenmiller said the company focuses on removing the barriers between patients and the care they often need.

“Scott’s leadership will sharpen our execution, accelerate innovation, and strengthen how we deliver measurable outcomes,” Truckenmiller added.

Filosi was not reached for comment at the time of Valeris’ news release announcing his appointment.

Valeris has headquarters in Morrisville, NC, and Jeffersonville, Ind.